NCT00982293

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

A Randomized, Double Blind, Placebo Controlled Study of the Application of Magnetic Fields Using the Resonator in Adjunctive Management of Type 2 Diabetes Mellitus, Pilot Study II

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 165 (estimated)
• Sponsor: pico-tesla Magnetic Therapies, LLC · Industry
• Sex: All
• Age: 21 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to see if using a device called the Resonator, that puts out very low level electromagnetic fields, effects blood glucose and A1c levels in people with Type 2 Diabetes.

Detailed description

The purpose of this pilot study is to determine whether application of magnetic fields generated by the Resonator TM, as an adjunctive therapy to oral medications results in statistically significant reductions in fasting blood glucose levels, post prandial glucose levels and hemoglobin A1c levels. The study will also investigate any induced changes in serum lipids.

Conditions

• Type 2 Diabetes

Interventions

Type	Name	Description
DEVICE	Resonator device	Low level electromagnetic fields for whole body immersion, 3 times weekly for 13 weeks (39) sessions of approximately 11/2 hours each.
DEVICE	Resonator device - sham	Treatment, 3 times weekly for 13 weeks (39) sessions - device will not be "on"

Timeline

• Start date: 2009-09-01
• Primary completion: 2011-05-01
• Completion: 2011-05-01
• First posted: 2009-09-23
• Last updated: 2011-05-05

Locations

1 site across 1 country: United States